These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 12441023)

  • 1. Current update of hormonal and psychotropic drug treatment of premenstrual dysphoric disorder.
    Freeman EW
    Curr Psychiatry Rep; 2002 Dec; 4(6):435-40. PubMed ID: 12441023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management strategies for premenstrual syndrome/premenstrual dysphoric disorder.
    Jarvis CI; Lynch AM; Morin AK
    Ann Pharmacother; 2008 Jul; 42(7):967-78. PubMed ID: 18559957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of premenstrual dysphoric disorder.
    Rapkin AJ; Lewis EI
    Womens Health (Lond); 2013 Nov; 9(6):537-56. PubMed ID: 24161307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premenstrual syndrome: A mini review.
    Ryu A; Kim TH
    Maturitas; 2015 Dec; 82(4):436-40. PubMed ID: 26351143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's Stopping Us? Using GnRH Analogs With Stable Hormone Addback in Treatment-Resistant Premenstrual Dysphoric Disorder: Practical Guidelines and Risk-Benefit Analysis for Long-term Therapy.
    Wagner-Schuman M; Kania A; Barone JC; Ross JM; Mulvihill A; Eisenlohr-Moul TA
    J Clin Psychiatry; 2023 Jun; 84(4):. PubMed ID: 37341478
    [No Abstract]   [Full Text] [Related]  

  • 6. [Premenstrual syndrome and premenstrual dysphoric disorder-Overview on pathophysiology, diagnostics and treatment].
    Haußmann J; Goeckenjan M; Haußmann R; Wimberger P
    Nervenarzt; 2024 Mar; 95(3):268-274. PubMed ID: 38393358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premenstrual syndrome and premenstrual dysphoric disorder in adolescents.
    Itriyeva K
    Curr Probl Pediatr Adolesc Health Care; 2022 May; 52(5):101187. PubMed ID: 35534402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A scoping review of hormonal clinical trials in menstrual cycle-related brain disorders: Studies in premenstrual mood disorder, menstrual migraine, and catamenial epilepsy.
    Barone JC; Butler MP; Ross A; Patterson A; Wagner-Schuman M; Eisenlohr-Moul TA
    Front Neuroendocrinol; 2023 Oct; 71():101098. PubMed ID: 37619655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of premenstrual dysphoric disorder: an update.
    Steiner M; Born L
    Int Clin Psychopharmacol; 2000 Nov; 15 Suppl 3():S5-17. PubMed ID: 11195269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder.
    Rapkin A
    Psychoneuroendocrinology; 2003 Aug; 28 Suppl 3():39-53. PubMed ID: 12892989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premenstrual dysphoric disorder and severe premenstrual syndrome in adolescents.
    Rapkin AJ; Mikacich JA
    Paediatr Drugs; 2013 Jun; 15(3):191-202. PubMed ID: 23529867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management.
    Steiner M
    J Psychiatry Neurosci; 2000 Nov; 25(5):459-68. PubMed ID: 11109297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Pharmacological Approaches to the Management of Premenstrual Dysphoric Disorder.
    Sundström-Poromaa I; Comasco E
    CNS Drugs; 2023 May; 37(5):371-379. PubMed ID: 37171547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An animal model of premenstrual dysphoric disorder sensitive to antidepressants.
    Schneider T; Popik P
    Curr Protoc Neurosci; 2009 Jan; Chapter 9():Unit 9.31. PubMed ID: 19170024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premenstrual Syndrome: Evidence-based Evaluation and Treatment.
    Appleton SM
    Clin Obstet Gynecol; 2018 Mar; 61(1):52-61. PubMed ID: 29298169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of fluoxetine in the treatment of premenstrual dysphoric disorder.
    Romano S; Judge R; Dillon J; Shuler C; Sundell K
    Clin Ther; 1999 Apr; 21(4):615-33; discussion 613. PubMed ID: 10363729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder.
    Freeman EW
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():27-34; discussion 42-3. PubMed ID: 12659404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal management of premenstrual syndrome.
    Usman SB; Indusekhar R; O'Brien S
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):251-60. PubMed ID: 17761457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premenstrual dysphoric disorder. A guide for the treating clinician.
    Elliott H
    N C Med J; 2002; 63(2):72-5. PubMed ID: 12063908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteal phase administration of agents for the treatment of premenstrual dysphoric disorder.
    Freeman EW
    CNS Drugs; 2004; 18(7):453-68. PubMed ID: 15139800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.